Vancomycin 10gm Inj, 1 Vial
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is typically administered as an infusion into a vein over a period of time. In some cases, it may be given orally or through a feeding tube instead of as an injection, if deemed necessary by your healthcare provider.
Storing and Disposing of Your Medication
If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage procedures.
Missing a Dose
If you miss a dose, contact your doctor to determine the best course of action.
Lifestyle & Tips
- Report any changes in hearing or ringing in the ears immediately.
- Report any decrease in urination or swelling.
- Inform healthcare providers about all other medications, including over-the-counter drugs and supplements.
- Stay well-hydrated unless otherwise instructed by your doctor.
Available Forms & Alternatives
Available Strengths:
- Vancomycin 1000mg Inj
- Vancomycin 500mg Vial Forinjection
- Vancomycin 500mg Inj, 1 Vial
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 1000mg Inj (ad-Vantage)
- Vancomycin 5gm Inj, 1 Vial
- Vancomycin 750mg Inj, 1 Vial
- Vancomycin 1gm Inj, 1 Vial
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin 1gm/200m Inj 12x200ml
- Vancomycin 250mg/5ml Oral Solution
- Vancomycin 10gm Inj, 1 Vial
- Vancomycin 1.25gm Inj 1 Vial
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 25mg/ml Oral Soln 300ml
- Vancomycin 25mg/ml Oral Soln 150ml
- Vancomycin 50mg/ml Oral Solution
- Vancomycin 1.5mg Inj, 1 Vial
- Vancomycin 1.75gm/350ml Inj, 350ml
- Vancomycin 750mg/150ml Inj, 150ml
- Vancomycin 1.5gm/300ml Inj, 300ml
- Vancomycin 500mg/100ml Inj, 100ml
- Vancomycin 125mg Capsules
- Vancomycin 250mg Capsules
- Vancomycin Hcl 1.75gm Inj, 1 Vial
- Vancomycin Hcl 2gm Sdv Inj, 1 Vial
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, this medication can cause severe and potentially life-threatening side effects. If you experience any of the following symptoms, contact your doctor or seek medical attention immediately:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Severe skin reactions, such as:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands
If you receive this medication through a vein (intravenous injection):
+ Fever
+ Chills
+ Sore throat
+ Pain when passing urine
+ Changes in balance
+ Flushing
+ Rash on the face, neck, trunk, and arms during infusion
If the medication is administered too quickly, you may experience:
+ Shortness of breath or wheezing
+ Itching
+ Muscle pain
+ Chest pain
+ Signs of low blood pressure, such as dizziness or fainting
If you notice any signs of tissue damage at the injection site, such as:
+ Redness
+ Burning
+ Pain
+ Swelling
+ Blisters
+ Skin sores
+ Leaking of fluid
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or do not go away:
Diarrhea
Stomach pain
Upset stomach
Vomiting
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Redness, flushing, itching, or rash on the upper body (Red Man Syndrome)
- Dizziness, ringing in the ears (tinnitus), or hearing loss
- Decreased urination, swelling in legs or feet (signs of kidney problems)
- Fever, chills, sore throat (signs of low white blood cell count)
- Pain, redness, or swelling at the injection site
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, any of its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
All medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial to ensure safe use and avoid potential interactions.
* Any existing health problems, as this medication may interact with other medical conditions or drugs.
To guarantee your safety, do not start, stop, or change the dosage of any medication without first consulting your doctor. It is vital to verify that it is safe to take this medication in combination with your other medications and health conditions. Your doctor and pharmacist will work together to ensure that all your medications, including this one, are safe and appropriate for you to take.
Precautions & Cautions
If you have a history of kidney problems, such as kidney failure, notify your doctor, as this medication can cause kidney issues. Your doctor will likely recommend regular blood work and other laboratory tests to monitor your condition.
Long-term use of this medication may increase the risk of permanent hearing loss. Do not exceed the prescribed duration of treatment, and immediately report any changes in your hearing or symptoms of hearing loss to your doctor. You may need to undergo hearing tests during treatment, so be sure to discuss this with your doctor.
Use this medication only for the recommended duration, as prolonged use can lead to a second infection.
Antibiotics, including this medication, can cause diarrhea, which may be mild or severe. In rare cases, a severe form of diarrhea called Clostridioides difficile-associated diarrhea (CDAD) can occur, potentially leading to life-threatening bowel problems. CDAD may develop during or after treatment, sometimes several months later. If you experience stomach pain, cramps, or loose, watery, or bloody stools, contact your doctor promptly. Before treating diarrhea, consult with your doctor.
This medication is not intended for injection into the eye, as it can cause severe eye problems, including permanent vision loss.
If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.
If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks to you and your baby. If you are of childbearing age, your doctor may require a pregnancy test before starting treatment to confirm that you are not pregnant.
Overdose Information
Overdose Symptoms:
- Severe kidney damage (nephrotoxicity)
- Hearing loss (ototoxicity)
- Hypotension
- Dizziness
- Tinnitus
What to Do:
Treatment is supportive. Hemodialysis may be useful in removing vancomycin from the blood in cases of severe overdose or renal failure. Contact a poison control center immediately (e.g., 1-800-222-1222 in the US).
Drug Interactions
Major Interactions
- Aminoglycosides (e.g., gentamicin, tobramycin, amikacin): Increased risk of nephrotoxicity and ototoxicity.
- Loop diuretics (e.g., furosemide, bumetanide): Increased risk of ototoxicity.
- Other nephrotoxic drugs (e.g., amphotericin B, cyclosporine, tacrolimus, NSAIDs): Increased risk of nephrotoxicity.
Moderate Interactions
- Neuromuscular blocking agents (e.g., succinylcholine, rocuronium): May prolong neuromuscular blockade.
- Metformin: Vancomycin may increase metformin concentrations by inhibiting renal tubular secretion (theoretical, clinical significance unclear).
Monitoring
Baseline Monitoring
Rationale: Vancomycin is primarily renally eliminated; baseline assessment is crucial for dosing and to monitor for nephrotoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline for potential ototoxicity.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline and monitor for neutropenia or thrombocytopenia.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Prior to the 4th or 5th dose (at steady state) and then at least weekly, or more frequently if renal function changes or dose adjustments are made.
Target: 10-15 mcg/mL for most infections; 15-20 mcg/mL for serious infections (e.g., endocarditis, osteomyelitis, meningitis, HAP/VAP, bacteremia with MRSA).
Action Threshold: Levels <10 mcg/mL may indicate subtherapeutic dosing; levels >20 mcg/mL increase risk of toxicity (nephrotoxicity, ototoxicity). Adjust dose or interval accordingly.
Frequency: At least 2-3 times per week, or daily in critically ill patients or those receiving concomitant nephrotoxic agents.
Target: Within patient's baseline range.
Action Threshold: Increase in SCr by ≥0.5 mg/dL or ≥50% from baseline (whichever is greater) on consecutive measurements, or significant decrease in urine output. Consider dose adjustment or discontinuation.
Frequency: Weekly, especially during prolonged therapy.
Target: Within normal limits.
Action Threshold: Neutropenia (ANC <1000 cells/mm³) or thrombocytopenia. Consider discontinuation if severe.
Symptom Monitoring
- Signs of nephrotoxicity (decreased urine output, swelling, fatigue)
- Signs of ototoxicity (tinnitus, hearing loss, vertigo)
- Signs of Red Man Syndrome (flushing, rash, pruritus, urticaria, hypotension, tachycardia during or shortly after infusion)
- Signs of hypersensitivity reactions (rash, fever, chills)
- Signs of phlebitis/thrombophlebitis at infusion site
Special Patient Groups
Pregnancy
Vancomycin is classified as Pregnancy Category C. It should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Limited human data suggest no increased risk of major birth defects, but animal studies are lacking or show adverse effects. Therapeutic drug monitoring is essential to maintain appropriate levels and minimize fetal exposure.
Trimester-Specific Risks:
Lactation
Vancomycin is excreted into breast milk in small amounts. Oral absorption by the infant is poor, so systemic effects on the infant are unlikely. However, potential risks include alteration of infant gut flora, direct effects on the infant (e.g., ototoxicity, nephrotoxicity, though unlikely due to poor absorption), and interference with interpretation of culture results if fever workup is needed. Use with caution; monitor infant for adverse effects.
Pediatric Use
Dosing is weight-based and often requires more frequent administration than in adults due to higher clearance rates. Therapeutic drug monitoring (TDM) is critical in all pediatric age groups, especially neonates and infants, due to variability in pharmacokinetics and immature renal function. Close monitoring for nephrotoxicity and ototoxicity is essential.
Geriatric Use
Elderly patients are more likely to have age-related decreases in renal function, which can prolong vancomycin half-life and increase the risk of accumulation and toxicity (nephrotoxicity, ototoxicity). Dosing should be carefully adjusted based on renal function, and therapeutic drug monitoring is highly recommended. Close monitoring for adverse effects is crucial.
Clinical Information
Clinical Pearls
- Always administer vancomycin IV infusions slowly over at least 60 minutes (or longer for doses >1g) to prevent Red Man Syndrome.
- Therapeutic drug monitoring (TDM) of trough levels is essential for optimizing efficacy and minimizing toxicity, especially in patients with renal impairment, critical illness, or those receiving prolonged therapy.
- Hydration is important to help prevent nephrotoxicity.
- Vancomycin is ineffective against Gram-negative bacteria and atypical organisms.
- Oral vancomycin is used ONLY for Clostridioides difficile infection (CDI) and is not absorbed systemically; IV vancomycin is NOT effective for CDI.
Alternative Therapies
- Linezolid (for MRSA, VRE)
- Daptomycin (for MRSA, VRE)
- Ceftaroline (for MRSA)
- Tedizolid (for MRSA)
- Dalbavancin (for MRSA)
- Oritavancin (for MRSA)
- Quinupristin/dalfopristin (for MRSA, VRE)